{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:24:51Z","timestamp":1769387091650,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,25]]},"DOI":"10.7759\/cureus.102259","type":"journal-article","created":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T15:36:08Z","timestamp":1769355368000},"source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Myo-Inositol Supplementation During Pregnancy on Fetal and Maternal Outcomes: Results of the Myo-Inositol for the Prevention of Gestational Diabetes Mellitus (MiGDM) Randomized Double-Blind, Placebo-Controlled Pilot Trial"],"prefix":"10.7759","author":[{"given":"Gbemisola","family":"Okunoye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinnu","family":"George Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Terranegra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim M","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.867099","article-title":"The impact of nutritional supplementation during pregnancy on the incidence of gestational diabetes and glycaemia control","volume":"9","author":"Ibrahim I","year":"2022","unstructured":"Ibrahim I, Bashir M, Singh P, Al Khodor S, Abdullahi H. The impact of nutritional supplementation during pregnancy on the incidence of gestational diabetes and glycaemia control. Front Nutr. 2022, 9:867099. 10.3389\/fnut.2022.867099","journal-title":"Front Nutr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00162.2019","article-title":"The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment","volume":"318","author":"Cabrera-Cruz H","year":"2020","unstructured":"Cabrera-Cruz H, Or\u00f3stica L, Plaza-Parrochia F, Torres-Pinto I, Romero C, Vega M. The insulin-sensitizing mechanism of myo-inositol is associated with AMPK activation and GLUT-4 expression in human endometrial cells exposed to a PCOS environment. Am J Physiol Endocrinol Metab. 2020, 318:E237-48. 10.1152\/ajpendo.00162.2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcme.2020.03.005","article-title":"Inositols and metabolic disorders: from farm to bedside","volume":"10","author":"Caputo M","year":"2020","unstructured":"Caputo M, Bona E, Leone I, et al.. Inositols and metabolic disorders: from farm to bedside. J Tradit Complement Med. 2020, 10:252-9. 10.1016\/j.jtcme.2020.03.005","journal-title":"J Tradit Complement Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2013.05.011","article-title":"Potential role and therapeutic interests of myo-inositol in metabolic diseases","volume":"95","author":"Croze ML","year":"2013","unstructured":"Croze ML, Soulage CO. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie. 2013, 95:1811-27. 10.1016\/j.biochi.2013.05.011","journal-title":"Biochimie"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3915253","article-title":"Myoinositol in the prevention of gestational diabetes mellitus: is it sensible?","volume":"2019","author":"Sobota-Grzeszyk A","year":"2019","unstructured":"Sobota-Grzeszyk A, Ku\u017amicki M, Szamatowicz J. Myoinositol in the prevention of gestational diabetes mellitus: is it sensible?. J Diabetes Res. 2019, 2019:3915253. 10.1155\/2019\/3915253","journal-title":"J Diabetes Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-1371","article-title":"Myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study","volume":"36","author":"D'Anna R","year":"2013","unstructured":"D'Anna R, Scilipoti A, Giordano D, et al.. Myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study. Diabetes Care. 2013, 36:854-7. 10.2337\/dc12-1371","journal-title":"Diabetes Care"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2010.00107","article-title":"D-chiro-inositol glycans in insulin signaling and insulin resistance","volume":"16","author":"Larner J","year":"2010","unstructured":"Larner J, Brautigan DL, Thorner MO. D-chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med. 2010, 16:543-52. 10.2119\/molmed.2010.00107","journal-title":"Mol Med"},{"key":"ref8","article-title":"Inositol: history of an effective therapy for polycystic ovary syndrome","volume":"18","author":"Bizzarri M","year":"2014","unstructured":"Bizzarri M, Carlomagno G. Inositol: history of an effective therapy for polycystic ovary syndrome. Eur Rev Med Pharmacol Sci. 2014, 18:1896-903.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011507.pub2","article-title":"Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes","volume":"2015","author":"Crawford TJ","year":"2015","unstructured":"Crawford TJ, Crowther CA, Alsweiler J, Brown J. Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes. Cochrane Database Syst Rev. 2015, 2015:CD011507. 10.1002\/14651858.CD011507.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2018.1428303","article-title":"The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: a meta-analysis of randomized controlled trials","volume":"32","author":"Zhang H","year":"2019","unstructured":"Zhang H, Lv Y, Li Z, Sun L, Guo W. The efficacy of myo-inositol supplementation to prevent gestational diabetes onset: a meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med. 2019, 32:2249-55. 10.1080\/14767058.2018.1428303","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/dc23-S015","article-title":"15. Management of diabetes in pregnancy: standards of care in diabetes-2023","volume":"46","author":"ElSayed NA","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al.. 15. Management of diabetes in pregnancy: standards of care in diabetes-2023. Diabetes Care. 2023, 46:S254-66. 10.2337\/dc23-S015","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055314","article-title":"Effect of antenatal dietary myo-inositol supplementation on the incidence of gestational diabetes mellitus and fetal outcome: protocol for a double-blind randomised controlled trial","volume":"12","author":"Ibrahim I","year":"2022","unstructured":"Ibrahim I, Abdullahi H, Fagier Y, Ortashi O, Terrangera A, Okunoye G. Effect of antenatal dietary myo-inositol supplementation on the incidence of gestational diabetes mellitus and fetal outcome: protocol for a double-blind randomised controlled trial. BMJ Open. 2022, 12:e055314. 10.1136\/bmjopen-2021-055314","journal-title":"BMJ Open"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-050110","article-title":"Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study","volume":"12","author":"Amaefule CE","year":"2022","unstructured":"Amaefule CE, Drymoussi Z, Gonzalez Carreras FJ, et al.. Myo-inositol nutritional supplement for prevention of gestational diabetes (EMmY): a randomised, placebo-controlled, double-blind pilot trial with nested qualitative study. BMJ Open. 2022, 12:e050110. 10.1136\/bmjopen-2021-050110","journal-title":"BMJ Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9132052","article-title":"The effectiveness of myo-inositol and d-chiro inositol treatment in type 2 diabetes","volume":"2016","author":"Pintaudi B","year":"2016","unstructured":"Pintaudi B, Di Vieste G, Bonomo M. The effectiveness of myo-inositol and d-chiro inositol treatment in type 2 diabetes. Int J Endocrinol. 2016, 2016:9132052. 10.1155\/2016\/9132052","journal-title":"Int J Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.15605\/jafes.038.02.11","article-title":"The efficacy and safety of myo-inositol supplementation for the prevention of gestational diabetes mellitus in overweight and obese pregnant women: a systematic review and meta-analysis","volume":"38","author":"Factor PA","year":"2023","unstructured":"Factor PA, Corpuz H. The efficacy and safety of myo-inositol supplementation for the prevention of gestational diabetes mellitus in overweight and obese pregnant women: a systematic review and meta-analysis. J ASEAN Fed Endocr Soc. 2023, 38:102-12. 10.15605\/jafes.038.02.11","journal-title":"J ASEAN Fed Endocr Soc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2015.1121478","article-title":"Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial","volume":"29","author":"Santamaria A","year":"2016","unstructured":"Santamaria A, Di Benedetto A, Petrella E, et al.. Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial. J Matern Fetal Neonatal Med. 2016, 29:3234-7. 10.3109\/14767058.2015.1121478","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2013.766691","article-title":"Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial","volume":"26","author":"Matarrelli B","year":"2013","unstructured":"Matarrelli B, Vitacolonna E, D'Angelo M, Pavone G, Mattei PA, Liberati M, Celentano C. Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. J Matern Fetal Neonatal Med. 2013, 26:967-72. 10.3109\/14767058.2013.766691","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000958","article-title":"Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial","volume":"126","author":"D'Anna R","year":"2015","unstructured":"D'Anna R, Di Benedetto A, Scilipoti A, et al.. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial. Obstet Gynecol. 2015, 126:310-5. 10.1097\/AOG.0000000000000958","journal-title":"Obstet Gynecol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-022-00862-5","article-title":"Myo-inositol supplementation for prevention of gestational diabetes mellitus in overweight and obese pregnant women: a systematic review and meta-analysis","volume":"14","author":"Mashayekh-Amiri S","year":"2022","unstructured":"Mashayekh-Amiri S, Mohammad-Alizadeh-Charandabi S, Abdolalipour S, Mirghafourvand M. Myo-inositol supplementation for prevention of gestational diabetes mellitus in overweight and obese pregnant women: a systematic review and meta-analysis. Diabetol Metab Syndr. 2022, 14:93. 10.1186\/s13098-022-00862-5","journal-title":"Diabetol Metab Syndr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1623699","article-title":"Myo-inositol supplementation in gestational diabetes mellitus: is there any interference with diet?","volume":"12","author":"Ahmed SH","year":"2025","unstructured":"Ahmed SH, Ibrahim I, Abdullahi H, et al.. Myo-inositol supplementation in gestational diabetes mellitus: is there any interference with diet?. Front Nutr. 2025, 12:1623699. 10.3389\/fnut.2025.1623699","journal-title":"Front Nutr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450136-the-effect-of-myo-inositol-supplementation-during-pregnancy-on-fetal-and-maternal-outcomes-results-of-the-myo-inositol-for-the-prevention-of-gestational-diabetes-mellitus-migdm-randomized-double-blind-placebo-controlled-pilot-trial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T15:36:09Z","timestamp":1769355369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450136-the-effect-of-myo-inositol-supplementation-during-pregnancy-on-fetal-and-maternal-outcomes-results-of-the-myo-inositol-for-the-prevention-of-gestational-diabetes-mellitus-migdm-randomized-double-blind-placebo-controlled-pilot-trial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.102259","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,25]]}}}